Penzberg, Germany

Markus Strasser



 

Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 15(Granted Patents)


Company Filing History:


Years Active: 2016-2025

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations by Inventor Markus Strasser in Antibody Purification

Introduction

Markus Strasser, located in Penzberg, Germany, is an accomplished inventor with a notable record of innovations in the field of biotechnology. He has been instrumental in developing efficient methods for antibody purification, which are critical for advancements in pharmaceutical manufacturing.

Latest Patents

Strasser holds two patents, both of which focus on an optimized method for antibody capturing through mixed mode chromatography. This innovative technique allows for the direct purification of antibodies from clarified cell culture supernatants using advanced materials like Streamline CST and Capto MMC. By effectively removing both product-related impurities such as aggregates and fragments, and process-related impurities including host cell protein and media components, Strasser's method achieves a purity level comparable to classical protein A affinity chromatography.

Career Highlights

Markus Strasser is currently associated with Hoffmann-La Roche Inc., a globally recognized leader in pharmaceuticals and diagnostics. His contributions to developing more efficient antibody purification processes have significantly influenced industry standards and practices, promoting higher quality in therapeutic antibody production.

Collaborations

Throughout his career, Strasser has collaborated with several esteemed colleagues, including Roberto Falkenstein and Thorsten Lemm. Their combined expertise in biochemistry and biotechnology has facilitated innovative approaches to tackle complex challenges in the field of antibody purification.

Conclusion

In summary, inventor Markus Strasser has made significant strides in the biotechnology sector through his patented methods for antibody purification. His work not only enhances purification processes but also contributes to the broader goals of improving therapeutic efficacy. As he continues to innovate at Hoffmann-La Roche Inc., the impact of his inventions is sure to resonate within the industry for years to come.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…